Precision Medicine in Hematologic Malignancies: The Example of Blincyto in B-ALL & a CD22 CAR T in NHL
- Exploring blincyto clinical response and biomarkers associated with response in B-ALL
- Reviewing CD22 CAR T clinical response, clinical pharmacology and biomarkers associated with response in NHL
- Showcasing baseline determinants of response and/or resistance